Chemotherapy: The Protocol revolution (Pharmaceutiques, May 2006)
The oncology market is currently enjoying spectacular growth. New therapeutic approaches are finally producing positive outcomes and turning into market launches that are set to propagate over the next three years. With 60 oncology molecules currently in Phase 3, either pre-registration or already registered, oncology is predicted to be the largest single business sector in value terms by 2009.
Dr Pierre Anhoury from IMS Health discusses the issues in the May edition of Pharmaceutiques. Download it here.